198 related articles for article (PubMed ID: 11418008)
1. Detection of the mutated K-Ras biomarker in colorectal carcinoma.
Doolittle BR; Emanuel J; Tuttle C; Costa J
Exp Mol Pathol; 2001 Jun; 70(3):289-301. PubMed ID: 11418008
[TBL] [Abstract][Full Text] [Related]
2. Frequent detection of K-ras mutation in stool samples of colorectal carcinoma patients after improved DNA extraction: comparison with tissue samples.
Ito Y; Kobayashi S; Taniguchi T; Kainuma O; Hara T; Ochiai T
Int J Oncol; 2002 Jun; 20(6):1263-8. PubMed ID: 12012008
[TBL] [Abstract][Full Text] [Related]
3. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
[TBL] [Abstract][Full Text] [Related]
4. Noninvasive detection through REMS-PCR technique of K-ras mutations in stool DNA of patients with colorectal cancer.
Mixich F; Ioana M; Voinea F; Săftoiu A; Ciurea T
J Gastrointestin Liver Dis; 2007 Mar; 16(1):5-10. PubMed ID: 17410282
[TBL] [Abstract][Full Text] [Related]
5. K-ras mutation: early detection in molecular diagnosis and risk assessment of colorectal, pancreas, and lung cancers--a review.
Minamoto T; Mai M; Ronai Z
Cancer Detect Prev; 2000; 24(1):1-12. PubMed ID: 10757118
[TBL] [Abstract][Full Text] [Related]
6. Correlation of K-ras codon 12 mutations in human feces and ages of patients with colorectal cancer (CRC).
Chien CC; Chen SH; Liu CC; Lee CL; Yang RN; Yang SH; Huang CJ
Transl Res; 2007 Feb; 149(2):96-102. PubMed ID: 17240321
[TBL] [Abstract][Full Text] [Related]
7. Detection of K-ras mutations in DNAs isolated from feces of patients with colorectal tumors by mutant-allele-specific amplification (MASA).
Hasegawa Y; Takeda S; Ichii S; Koizumi K; Maruyama M; Fujii A; Ohta H; Nakajima T; Okuda M; Baba S
Oncogene; 1995 Apr; 10(7):1441-5. PubMed ID: 7731696
[TBL] [Abstract][Full Text] [Related]
8. Quantitative detection of mutant alleles of the K-ras gene with minor groove binder-conjugated fluorogenic DNA probes.
Itabashi T; Maesawa C; Uchiyama M; Higuchi T; Masuda T
Int J Oncol; 2004 Mar; 24(3):687-96. PubMed ID: 14767554
[TBL] [Abstract][Full Text] [Related]
9. [Value of fecal and blood adenomatous polyposis coli gene and K-ras gene mutation detection in colorectal neoplasm screening].
Zhan J; Li X; Yu Z; Yuan YH; Hou J
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jul; 27(7):1018-21. PubMed ID: 17666342
[TBL] [Abstract][Full Text] [Related]
10. K-ras codon 12 and 13 mutations are correlated with differential patterns of tumor cell dissemination in colorectal cancer patients.
Conzelmann M; Linnemann U; Berger MR
Int J Oncol; 2004 Jun; 24(6):1537-44. PubMed ID: 15138598
[TBL] [Abstract][Full Text] [Related]
11. Persistence of K-ras mutations in plasma after colorectal tumor resection.
Lindforss U; Zetterquist H; Papadogiannakis N; Olivecrona H
Anticancer Res; 2005; 25(1B):657-61. PubMed ID: 15816642
[TBL] [Abstract][Full Text] [Related]
12. Detection of APC and k-ras mutations in the serum of patients with colorectal cancer.
Lauschke H; Caspari R; Friedl W; Schwarz B; Mathiak M; Propping P; Hirner A
Cancer Detect Prev; 2001; 25(1):55-61. PubMed ID: 11270422
[TBL] [Abstract][Full Text] [Related]
13. Reproducibility of a multitarget stool-based DNA assay for colorectal cancer detection.
Brand RE; Ross ME; Shuber AP
Am J Gastroenterol; 2004 Jul; 99(7):1338-41. PubMed ID: 15233675
[TBL] [Abstract][Full Text] [Related]
14. Sampling method as a key factor in identifying K-ras oncogene mutations in preneoplastic colorectal lesions.
Ronai Z; Minamoto T; Butler R; Tobi M; Luo FQ; Zang E; Esumi H; Sugimura T
Cancer Detect Prev; 1995; 19(6):512-7. PubMed ID: 8925520
[TBL] [Abstract][Full Text] [Related]
15. Multiple detection of genetic alterations in tumors and stool.
Rengucci C; Maiolo P; Saragoni L; Zoli W; Amadori D; Calistri D
Clin Cancer Res; 2001 Mar; 7(3):590-3. PubMed ID: 11297253
[TBL] [Abstract][Full Text] [Related]
16. High sensitivity scanning of colorectal tumors and matched plasma DNA for mutations in APC, TP53, K-RAS, and BRAF genes with a novel DHPLC fluorescence detection platform.
Lilleberg SL; Durocher J; Sanders C; Walters K; Culver K
Ann N Y Acad Sci; 2004 Jun; 1022():250-6. PubMed ID: 15251969
[TBL] [Abstract][Full Text] [Related]
17. Detection of stool DNA mutations before and after treatment of colorectal neoplasia.
Syngal S; Stoffel E; Chung D; Willett C; Schoetz D; Schroy P; Jagadeesh D; Morel K; Ross M
Cancer; 2006 Jan; 106(2):277-83. PubMed ID: 16342248
[TBL] [Abstract][Full Text] [Related]
18. [An application value of detecting K-ras and p53 gene mutation in the stool and pure pancreatic juice for diagnosis of early pancreatic cancer].
Lu X; Xu T; Qian J
Zhonghua Yi Xue Za Zhi; 2001 Sep; 81(17):1050-3. PubMed ID: 11758254
[TBL] [Abstract][Full Text] [Related]
19. Alterations of K-ras and p53 mutations in colorectal cancer patients in Central Europe.
König EA; Köves I; Raşinariu A; Popp AR; Kusser WC; Soyonki K; Kovács A; Glickman BW; Jeney A; Marcsek ZL
J Toxicol Environ Health A; 2001 Mar; 62(5):333-47. PubMed ID: 11261896
[TBL] [Abstract][Full Text] [Related]
20. Detecting K-ras and p53 gene mutation from stool and pancreatic juice for diagnosis of early pancreatic cancer.
Lu X; Xu T; Qian J; Wen X; Wu D
Chin Med J (Engl); 2002 Nov; 115(11):1632-6. PubMed ID: 12609076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
